Botfet / Company detail

ANIP

universe

ANI Pharmaceuticals, Inc.

biotech

Moat score54out of 100

The numbers

Financial metrics

Quality gate and thesis context

Roic5.6%

Gross Margin51.0%

Revenue Cagr42.2%

Fcf Conversion192.6%

Fcf Yield9.0%

Interest Coverage10.3x

Market Cap B$1.7B

Pe15.0

Quality PassPass

Founder LedNo

Thesis AlignedYes

Moat Quant54

Why it may endure

Moat breakdown

Quant: 54 · Curator: 0

Market Share Stability6

Network Effects6

Pricing Power20

Regulatory Moat16

Switching Costs6

Conviction0/10

Leadership0/10

Vision0/10

← Back to the full screener